401 POSTER A phase I study of enzastaurin (ENZ), an oral...

401 POSTER A phase I study of enzastaurin (ENZ), an oral PKC inhibitor, in combination with erlotinib (ERL) administered orally daily to patients with advanced solid malignancies

H.A. Wakelee, S.K. Padda, L. Chhatwani, M. San Pedro-Salcedo, Y. Krupitskaya, L. Musib, J.E. Latz
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72335-8
File:
PDF, 58 KB
english, 2008
Conversion to is in progress
Conversion to is failed